• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性甲状旁腺功能亢进症手术患者围手术期FGF23的变化

Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism.

作者信息

Fořtová Magdaléna, Hanousková Lenka, Valkus Martin, Čepová Jana, Průša Richard, Kotaška Karel

机构信息

Department of Medical Chemistry and Clinical Biochemistry, Charles University, Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.

出版信息

Endocr Connect. 2022 Jan 31;11(1):e210430. doi: 10.1530/EC-21-0430.

DOI:10.1530/EC-21-0430
PMID:34860179
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8859952/
Abstract

BACKGROUND

Fibroblast growth factor 23 (FGF23) is a key regulator of urine phosphate excretion. The aim of the study was to investigate the perioperative (intraoperative and postoperative) changes of plasma intact and C-terminal FGF23 (iFGF23, cFGF23) concentrations in patients with primary hyperparathyroidism (pHPT) submitted to surgery.

MATERIALS AND METHODS

The study involved 38 adult patients with pHPT caused by adenoma. Parathyroid hormone (PTH) levels were investigated intraoperatively (just before the incision and 10 min after adenoma excision). cFGF23, iFGF23, phosphate, estimated glomerular filtration rate (eGFR), and procollagen type 1 N-terminal propetide (P1NP) were measured intraoperatively and postoperatively (next day after the surgery).

RESULTS

PTH levels decreased intraoperatively (13.10 pmol/L vs 4.17 pmol/L, P< 0.0001). FGF23 levels measured intraoperatively were at the upper level of reference interval. cFGF23 decreased postoperatively compared with the values measured just before the incision (cFGF23: 89.17 RU/mL vs 22.23 RU/mL, P< 0.0001). iFGF23 decreased as well, but the postoperative values were low. Postoperative inorganic phosphate values increased (1.03 mmol/L vs 0.8 mmol/L, P= 0.0025). We proved significant negative correlation of perioperative FGF23 with inorganic phosphate (cFGF23: Spearman's r = -0.253, P= 0.0065; iFGF23: Spearman's r = -0.245, P= 0.0085). We also found that FGF23 values just before incision correlated with eGFR (cystatin C) (cFGF23: Spearman's r = -0.499, P= 0.0014; iFGF23: Spearman's r = -0.413, P= 0.01).

CONCLUSION

Intraoperative iFGF23 and cFGF23 did not change despite PTH decreased significantly. cFGF23 and iFGF23 significantly decreased 1 day after parathyroidectomy and are associated with increase of inorganic phosphate in pHPT patients. cFGF23 and iFGF23 just before incision correlated with eGFR (cystatin C). Similar results found in both iFGF23 and cFGF23 suggest that each could substitute the other.

摘要

背景

成纤维细胞生长因子23(FGF23)是尿磷排泄的关键调节因子。本研究旨在调查接受手术的原发性甲状旁腺功能亢进症(pHPT)患者围手术期(术中及术后)血浆完整FGF23和C端FGF23(iFGF23、cFGF23)浓度的变化。

材料与方法

本研究纳入38例由腺瘤引起的成人pHPT患者。术中(切口前及腺瘤切除后10分钟)检测甲状旁腺激素(PTH)水平。术中及术后(术后次日)检测cFGF23、iFGF23、磷酸盐、估算肾小球滤过率(eGFR)和I型前胶原N端前肽(P1NP)。

结果

术中PTH水平下降(13.10 pmol/L对4.17 pmol/L,P<0.0001)。术中检测的FGF23水平处于参考区间上限。与切口前测得的值相比,术后cFGF23下降(cFGF23:89.17 RU/mL对22.23 RU/mL,P<0.0001)。iFGF23也下降,但术后值较低。术后无机磷值升高(1.03 mmol/L对0.8 mmol/L,P=0.0025)。我们证明围手术期FGF23与无机磷呈显著负相关(cFGF23:Spearman相关系数r=-0.253,P=0.0065;iFGF23:Spearman相关系数r=-0.245,P=0.0085)。我们还发现切口前的FGF23值与eGFR(胱抑素C)相关(cFGF23:Spearman相关系数r=-0.499,P=0.0014;iFGF23:Spearman相关系数r=-0.413,P=0.01)。

结论

尽管PTH显著下降,但术中iFGF23和cFGF23并未改变。甲状旁腺切除术后1天,cFGF23和iFGF23显著下降,且与pHPT患者无机磷增加有关。切口前的cFGF23和iFGF23与eGFR(胱抑素C)相关。iFGF23和cFGF23的类似结果表明二者可相互替代。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd75/8859952/3575f5d0c6b0/EC-21-0430fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd75/8859952/173ea5e328d5/EC-21-0430fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd75/8859952/d83fe6073208/EC-21-0430fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd75/8859952/45bac9cf809d/EC-21-0430fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd75/8859952/3575f5d0c6b0/EC-21-0430fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd75/8859952/173ea5e328d5/EC-21-0430fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd75/8859952/d83fe6073208/EC-21-0430fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd75/8859952/45bac9cf809d/EC-21-0430fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd75/8859952/3575f5d0c6b0/EC-21-0430fig4.jpg

相似文献

1
Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism.原发性甲状旁腺功能亢进症手术患者围手术期FGF23的变化
Endocr Connect. 2022 Jan 31;11(1):e210430. doi: 10.1530/EC-21-0430.
2
Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.急性肾损伤和慢性低氧血症对小儿心脏手术患者成纤维细胞生长因子23水平的影响。
Pediatr Nephrol. 2016 Apr;31(4):661-9. doi: 10.1007/s00467-015-3257-5. Epub 2015 Nov 2.
3
Renal Clearance of Fibroblast Growth Factor-23 (FGF23) and its Fragments in Humans.人内源性成纤维细胞生长因子 23(FGF23)及其片段的肾清除率
J Bone Miner Res. 2022 Jun;37(6):1170-1178. doi: 10.1002/jbmr.4553. Epub 2022 Apr 25.
4
Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.慢性肾脏病合并心力衰竭患者红细胞分布宽度与成纤维细胞生长因子23裂解的关系
PLoS One. 2015 Jun 16;10(6):e0128994. doi: 10.1371/journal.pone.0128994. eCollection 2015.
5
Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR).血清 C 端成纤维细胞生长因子 23(cFGF23)水平与行经导管主动脉瓣置换术(TAVR)患者的 1 年死亡率相关。
Eur J Intern Med. 2021 Mar;85:98-107. doi: 10.1016/j.ejim.2020.09.022. Epub 2020 Nov 13.
6
Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.成纤维细胞生长因子 23(FGF23)与老年人的早期慢性肾脏病。
Nephrol Dial Transplant. 2014 Sep;29(9):1757-63. doi: 10.1093/ndt/gfu063. Epub 2014 Apr 11.
7
Phosphate control in reducing FGF23 levels in hemodialysis patients.控制血透患者血磷水平以降低成纤维细胞生长因子 23 水平。
PLoS One. 2018 Aug 7;13(8):e0201537. doi: 10.1371/journal.pone.0201537. eCollection 2018.
8
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.缺铁性贫血及其治疗对女性成纤维细胞生长因子 23 和磷稳态的影响。
J Bone Miner Res. 2013 Aug;28(8):1793-803. doi: 10.1002/jbmr.1923.
9
Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation.老年人早期肾功能损害时肾-骨轴调节因子、炎症和铁状态的改变及维生素 D 补充的影响。
Age Ageing. 2024 May 1;53(5). doi: 10.1093/ageing/afae096.
10
Biological variability of plasma intact and C-terminal FGF23 measurements.血浆完整和 C 端 FGF23 测量的生物学变异性。
J Clin Endocrinol Metab. 2012 Sep;97(9):3357-65. doi: 10.1210/jc.2012-1811. Epub 2012 Jun 11.

引用本文的文献

1
Phosphate metabolism: its impact on disorders of mineral metabolism.磷代谢:其对矿物质代谢紊乱的影响。
Endocrine. 2025 Apr;88(1):1-13. doi: 10.1007/s12020-024-04092-9. Epub 2024 Nov 11.
2
Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level.根据成纤维细胞生长因子 23 水平,血钙正常的甲状旁腺功能亢进症是甲状旁腺功能亢进症的早期阶段。
Front Endocrinol (Lausanne). 2023 Mar 30;14:1152464. doi: 10.3389/fendo.2023.1152464. eCollection 2023.

本文引用的文献

1
Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery?血钙正常的原发性甲状旁腺功能亢进症:甲状旁腺手术的作用是什么?
Ther Adv Endocrinol Metab. 2021 Feb 27;12:2042018821995370. doi: 10.1177/2042018821995370. eCollection 2021.
2
Osteocytic FGF23 and Its Kidney Function.成骨细胞源性 FGF23 及其肾功能。
Front Endocrinol (Lausanne). 2020 Aug 28;11:592. doi: 10.3389/fendo.2020.00592. eCollection 2020.
3
Discrepant glomerular filtration rate trends from creatinine and cystatin C in patients with chronic kidney disease: results from the KNOW-CKD cohort.
慢性肾脏病患者的肌酐和胱抑素 C 肾小球滤过率趋势差异:来自 KNOW-CKD 队列的结果。
BMC Nephrol. 2020 Jul 16;21(1):280. doi: 10.1186/s12882-020-01932-4.
4
Evaluation of Serum Level of FGF23 and 1,25(OH)D in Primary Hyperparathyroidism Patients Before and After Parathyroidectomy.甲状旁腺切除术前、后原发性甲状旁腺功能亢进患者血清FGF23和1,25(OH)D水平的评估
Int J Gen Med. 2020 Jun 11;13:289-295. doi: 10.2147/IJGM.S253246. eCollection 2020.
5
FGF23 and primary hyperparathyroidism: is there a link?成纤维细胞生长因子 23 与原发性甲状旁腺功能亢进症:二者之间存在关联吗?
Endokrynol Pol. 2020;71(4):306-312. doi: 10.5603/EP.a2020.0030. Epub 2020 Jun 29.
6
New Therapies for Hypophosphatemia-Related to FGF23 Excess.与 FGF23 过剩相关的低磷血症的新疗法。
Calcif Tissue Int. 2021 Jan;108(1):143-157. doi: 10.1007/s00223-020-00705-3. Epub 2020 Jun 5.
7
Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia.遗传性溶血性贫血患者中促红细胞生成素、成纤维细胞生长因子 23 和红细胞生成素之间的相互作用。
Blood Adv. 2020 Apr 28;4(8):1678-1682. doi: 10.1182/bloodadvances.2020001595.
8
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.成纤维细胞生长因子 23 在磷酸盐、铁代谢和红细胞生成的十字路口。
Nat Rev Nephrol. 2020 Jan;16(1):7-19. doi: 10.1038/s41581-019-0189-5. Epub 2019 Sep 13.
9
FGF23, Hypophosphatemia, and Emerging Treatments.成纤维细胞生长因子23、低磷血症与新兴治疗方法
JBMR Plus. 2019 May 13;3(8):e10190. doi: 10.1002/jbm4.10190. eCollection 2019 Aug.
10
Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.成纤维细胞生长因子 23 的生物学特性:从生理学到病理学。
Cold Spring Harb Perspect Med. 2018 May 1;8(5):a031260. doi: 10.1101/cshperspect.a031260.